Cargando…
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy
N-Acetylaspartate (NAA) is the second most abundant organic metabolite in the brain, but its physiological significance remains enigmatic. Toxic NAA accumulation appears to be the key factor for neurological decline in Canavan disease—a fatal neurometabolic disorder caused by deficiency in the NAA-d...
Autores principales: | von Jonquieres, Georg, Spencer, Ziggy H. T., Rowlands, Benjamin D., Klugmann, Claudia B., Bongers, Andre, Harasta, Anne E., Parley, Kristina E., Cederholm, Jennie, Teahan, Orla, Pickford, Russell, Delerue, Fabien, Ittner, Lars M., Fröhlich, Dominik, McLean, Catriona A., Don, Anthony S., Schneider, Miriam, Housley, Gary D., Rae, Caroline D., Klugmann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756261/ https://www.ncbi.nlm.nih.gov/pubmed/29116375 http://dx.doi.org/10.1007/s00401-017-1784-9 |
Ejemplares similares
-
Loss of Central Auditory Processing in a Mouse Model of Canavan Disease
por: von Jonquieres, Georg, et al.
Publicado: (2014) -
Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice
por: Fröhlich, Dominik, et al.
Publicado: (2022) -
Recombinant Human Myelin-Associated Glycoprotein Promoter Drives Selective AAV-Mediated Transgene Expression in Oligodendrocytes
por: von Jonquieres, Georg, et al.
Publicado: (2016) -
Glial Promoter Selectivity following AAV-Delivery to the Immature Brain
por: von Jonquieres, Georg, et al.
Publicado: (2013) -
Developmental delay and late onset HBSL pathology in hypomorphic Dars1(M256L) mice
por: Klugmann, Matthias, et al.
Publicado: (2022)